Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants

Heart

Volumn 101, Issue 10, 2015, Pages 788-793

  Van Dijck, Ine ^a   Budts, Werner ^a   Cools, Bjorn ^a   Eyskens, Benedicte ^a   Boshoff, Derize E ^a   Heying, Ruth ^a   Frerich, Stefan ^b   Vanagt, Ward Y ^b   Troost, Els ^a   Gewillig, Marc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; AGGREGATIBACTER; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTERIAL TRUNK; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOBACTERIUM; CHILD; CONTROLLED STUDY; CORYNEBACTERIUM PSEUDODIPHTHERITICUM; DISEASE FREE SURVIVAL; EIKENELLA CORRODENS; FEMALE; FOLLOW UP; HAEMOPHILUS; HOMOGRAFT VALVED CONDUIT; HUMAN; INCIDENCE; INFANT; KINGELLA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROSTHESIS IMPLANTATION; PULMONARY VALVE PROSTHESIS; PULMONARY VALVE STENOSIS; PULMONARY VALVED CONDUIT; RETROSPECTIVE STUDY; ROSS PROCEDURE; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS SANGUINIS; ADVERSE EFFECTS; BELGIUM; BIOPROSTHESIS; COMPARATIVE STUDY; DEVICES; ENDOCARDITIS, BACTERIAL; FACTUAL DATABASE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; PROSTHESIS; PULMONARY VALVE; RISK FACTOR; STENT; TERTIARY CARE CENTER; TIME; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BELGIUM; BIOPROSTHESIS; CARDIAC CATHETERIZATION; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PULMONARY VALVE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930668651     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306761     Document Type: Article

References (21)

1. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-5.
2. Gillespie MJ, Rome JJ, Levi DS, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv 2012;5:862-70.
3. Cheung G, Vejlstrup N, Ihlemann N, et al. Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. Int J Cardiol 2013;169:425-9.
4. Butera G, Milanesi O, Spadoni I, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv 2013;81:310-16.
5. Boshoff DE, Cools BL, Heying R, et al. Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc Interv 2013;81:987-95.
6. Cools B, Boshoff D, Heying R, et al. Follow-up after Melody revalvation: "aggressive" prestenting has nearly abolished stent fractures; endocarditis is a concern. Cardiol Young 2014;24:S138:P198 (abstract).
7. McElhinney DB, Benson LN, Eicken A, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv 2013;6:292-300.
8. Buber J, Bergersen L, Lock JE, et al. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv 2013;6:301-10.
9. Villafane J, Baker GH, Austin EH III, et al. Melody((R)) pulmonary valve bacterial endocarditis: experience in four pediatric patients and a review of the literature. Catheter Cardiovasc Interv 2014;84:212-18.
10. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
11. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
12. Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-72.
13. Matsuki O, Robles A, Gibbs S, et al. Long-term performance of 555 aortic homografts in the aortic position. Ann Thorac Surg 1988;46:187-91.
14. Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg 2007;32:133-42.
15. Meyns B, Jashari R, Gewillig M, et al. Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur J Cardiothorac Surg 2005;28:211-16.
16. Albanesi F, Sekarski N, Lambrou D, et al. Incidence and risk factors for Contegra graft infection following right ventricular outflow tract reconstruction: long-term results. Eur J Cardiothorac Surg 2014;45:1070-4.
17. Breymann T, Blanz U, Wojtalik MA, et al. European Contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg 2009;57:257-69.
18. Meyns B, Van Garsse L, Boshoff D, et al. The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J Thorac Cardiovasc Surg 2004;128:834-40.
19. Patel M, Iserin L, Bonnet D, et al. Atypical malignant late infective endocarditis of Melody valve. J Thorac Cardiovasc Surg 2012;143:e32-5.
20. Lockhart PB, Brennan MT, Thornhill M, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc 2009;140:1238-44.
21. Bhat DP, Forbes TJ, Aggarwal S. A case of life-threatening Staphylococcus aureus endocarditis involving percutaneous transcatheter prosthetic pulmonary valve. Congenit Heart Dis 2013;8:E161-4.